หน้าแรก
ค้นหา
Dr E Ann Yeh - Longer-term safety of B-cell therapies in MS
Longer-term safety of B-cell therapies in MS
แสดงข้อมูลเพิ่มเติม 1
Dr E Ann Yeh - Longer-term safety of B-cell therapies in MS
Dr Ann Yeh - The diagnosis of paediatric MS and excluding MS mimics
The Brain Conference 2021: Translational Research presentation: E Ann Yeh
The Future of Multiple Sclerosis Therapy
NVJC Ep. 46 Multiple Sclerosis/Autoimmune Neurology: Differentiating MS From AAQP4-NMOSD & MOGAD
Dr Maria Teresa Cencioni - B-cells in multiple sclerosis — from targeted depletion ...
Ben Thrower, MD: MiSfires: The Malfunctioning MS Immune System
B-Cell Depletion And Comparison Between These Drugs
Dr Evangeline Wassmer - Demyelinating disorders and childhood MS
Approaches to Managing MS in 2022: A Research Update - January 2022
MS Hangout ECTRIMS 2022 Amsterdam
Dr Veronique Miron - Glial interactions driving remyelination in MS
Jacqui is one of the first in the UK to get #Kesimpta for her #MS. She shares her experiences here.
Smouldering Multiple Sclerosis
ECTRIMS 2022: For People with MS (in English)
Dr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond
Viatris Multiple Sclerosis Webinar
Barry Singer, ECTRIMS 2022: Diroximel fumarate for RRMS – Phase 3 results from EVOLVE-MS-1
Lunch and Learn Ep.1 with Dr. Yeh
Kesimpta Shot Month #3 November 27, 2021
